- 0
Every year, thousands of people in the U.S. and Australia are given the wrong medication-not because of a mistake in diagnosis, but because two drug names look or sound almost identical. Look-alike and sound-alike (LASA) drug names are one of the most common causes of preventable medication errors. You might think pharmacists and nurses would catch these mix-ups easily, but when you’re rushing through 50 prescriptions in an hour, names like hydroCODONE a potent opioid pain reliever and hydroHYDRALAZINE a blood pressure medication can blur together on a screen or a handwritten label. This isn’t theoretical-it’s happening in hospitals, pharmacies, and even at home when patients misread their own labels.
What Makes Drug Names Confusing?
It’s not random. Research shows that drug names with 60-80% identical letters are the most likely to cause mix-ups. The U.S. Food and Drug Administration (FDA) the federal agency responsible for regulating medications in the United States has tracked over 3,000 confusing pairs. Some of the most dangerous include:
- vinBLAStine used for lymphoma vs. vinCRIStine used for leukemia
- CISplatin a chemotherapy drug vs. CARBOplatin another chemotherapy drug
- doXEPamine an antidepressant vs. doBUTamine a heart stimulant
These aren’t just minor spelling differences. Giving the wrong one can lead to organ failure, coma, or death. Even small changes-like one capitalized letter-can make the difference between life and death.
Tall Man Lettering: The Visual Lifesaver
The most widely used tool to fight this problem is called Tall Man Lettering (TML) a visual technique that capitalizes the differing parts of similar drug names. Instead of writing "hydrocodone," it becomes "hydroCODONE." Instead of "hydralazine," it’s "hydroHYDRALAZINE." The uppercase letters draw the eye to the key difference.
The FDA and the Institute for Safe Medication Practices (ISMP) a nonprofit organization dedicated to reducing medication errors have standardized TML rules:
- Capitalize 2-4 letters that create the clearest visual contrast
- Use consistent capitalization across all systems: EHRs, pharmacy labels, automated dispensers
- Apply minimum 12-point font size with 4.5:1 color contrast
Studies show TML reduces visual confusion by about 32%. At Johns Hopkins Hospital, combining TML with other safety steps cut LASA errors by 67% over two years. But TML alone isn’t enough. If one system shows "hydroCODONE" and another shows "hydrocodone," confusion returns.
Why TML Isn’t Enough
Here’s the hard truth: many pharmacies and hospitals still don’t use TML consistently. A 2022 survey of 1,247 pharmacists found that 65% saw inconsistent TML use across their systems. Nurses often switch between an EHR that uses tall man letters and a printed label that doesn’t. One ICU nurse on Reddit said: "The EHR shows it right, but the MAR doesn’t. I end up guessing." Handwritten prescriptions are still common-and they rarely use TML. In fact, 41% of LASA errors traced back to handwritten orders. Poor print quality on labels? That’s another 29%. Even if the system has TML, if the label is faded, smudged, or printed in small font, it’s useless.
And it’s not just about looks. Sound-alike names are just as dangerous. "Zyrtec" and "Zyprexa" sound alike. "Lopressor" and "Lopid"-you can hear the mix-up coming. The ALINE algorithm a phonetic analysis tool used to detect sound-alike drug names is better than older methods at catching these. But no computer can stop a tired nurse from mishearing "furosemide" as "hydrochlorothiazide" during a busy shift.
What You Can Do: A 3-Step Verification System
Whether you’re a pharmacist, nurse, or patient, here’s a simple, proven method to catch errors before they happen:
- Read the full label-every time. Don’t just glance at the first few letters. Say the full name out loud: "Hydro-CO-done. Hydro-HY-dral-azine."
- Confirm with someone else-if you’re unsure, ask a colleague to double-check. Studies show this cuts errors by 52%.
- Read it again before giving it-whether you’re handing it to a patient or putting it in a machine, read the label one last time. This final check catches 80% of remaining mistakes.
This isn’t extra work-it’s survival. At the University of California San Francisco Medical Center, pharmacists who spent just two extra minutes per high-risk drug saw their verification accuracy jump from 82% to 97%.
Technology That Actually Works
Barcode scanning is the most effective single tool. When a nurse scans a medication before giving it to a patient, the system checks the drug name, dose, patient, and time. If it doesn’t match, it stops everything. Studies show this prevents 89% of administration errors. But it requires investment: $153,000 per hospital on average.
Computer alerts help too-when they’re smart. Too many alerts cause "alert fatigue." A 2021 JAMA study found clinicians override 49% of LASA alerts because they’re too frequent or irrelevant. The fix? Only trigger alerts for high-risk pairs like insulin, opioids, and chemotherapy drugs. Done right, alert overrides drop from 73% to 31%.
The FDA’s computer analysis tool a system used to evaluate new drug names for potential confusion uses both BI-SIM an algorithm that measures visual similarity between drug names and ALINE an algorithm that measures phonetic similarity between drug names to predict confusion before a drug even hits the market. Between 2018 and 2023, it blocked 17 potentially dangerous drug names from being approved.
What’s Changing in 2025-2026
The FDA just added 12 new drug pairs to its TML list, bringing the total to 35. By December 2024, all U.S. healthcare systems must use TML for these. The National Council for Prescription Drug Programs an organization that sets standards for pharmacy data exchange released Version 3.0 of its LASA standard in January 2023-this lets systems talk to each other and flag risks in real time.
AI is stepping in too. Google’s Med-PaLM 2 can predict confusion with 89% accuracy, but it’s not replacing humans-it’s helping them. The Institute for Safe Medication Practices a nonprofit organization dedicated to reducing medication errors is pushing for mandatory TML across all U.S. settings by 2026. And in Australia? We’re watching closely. While we don’t have the same federal mandate yet, major hospitals in Sydney and Melbourne are already adopting these practices.
Final Advice: Don’t Trust Your Eyes Alone
Medication safety isn’t about being careful. It’s about building systems that make mistakes impossible. TML helps. Barcodes help. Alerts help. But none of them work if you skip steps because you’re in a hurry.
If you’re a patient: Always read your prescription label. If it looks like another drug you’ve taken before, ask your pharmacist: "Is this the same as [other drug]?" If you’re a healthcare worker: Slow down. Double-check. Speak the name out loud. Use the 3-step rule every time. And if you see a label without tall man letters? Report it. Change it. It might save a life.
What are look-alike and sound-alike (LASA) drug names?
Look-alike and sound-alike (LASA) drug names are medications with spelling or pronunciation that are very similar, making them easy to confuse. Examples include hydroCODONE and hydroHYDRALAZINE, or vinBLAStine and vinCRIStine. These mix-ups can lead to serious harm or death if the wrong drug is given.
What is tall man lettering?
Tall man lettering (TML) is a visual technique that uses uppercase letters to highlight the differences between similar drug names. For example, "hydroCODONE" instead of "hydrocodone." It helps pharmacists and nurses quickly spot the correct drug and reduces visual confusion by up to 32%.
How effective is tall man lettering at preventing errors?
Tall man lettering alone reduces visual confusion errors by about 32%. When combined with color coding and purpose-of-treatment notes, effectiveness jumps to 59%. But its success depends on consistent use across all systems-EHRs, labels, and automated dispensers.
Why do LASA errors still happen even with tall man lettering?
Errors still happen because TML isn’t always used consistently. Handwritten prescriptions often lack it, printed labels can be faded or too small, and different systems (like EHRs vs. MARs) sometimes display names differently. Human factors like fatigue, time pressure, and cognitive overload also play a big role.
What’s the best way to prevent LASA errors?
The most effective approach combines multiple layers: tall man lettering, barcode scanning, computer alerts for high-risk drugs, and a strict 3-step verification process-read the label, confirm with someone else, read it again before giving it. Barcode scanning alone prevents up to 89% of administration errors.